GCP
BDSX icon

Gill Capital Partners’s Biodesix BDSX Stock Holding History

Gill Capital Partners’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189 Buy
+13
New +$161 ﹤0.01% 661

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Gill Capital Partners's BDSX Position: Q1 2026 in Review

Gill Capital Partners opened a new position in Biodesix (BDSX) in Q1 2026: 13 shares worth $189. The stake represents ﹤0.01% of the portfolio and ranks #661 among its holdings.

40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Gill Capital Partners held 13 shares of Biodesix worth $189 as of Q1 2026.
  • Biodesix was a new Gill Capital Partners position in Q1 2026.
  • Biodesix made up ﹤0.01% of Gill Capital Partners's portfolio in Q1 2026, its #661 holding.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.